Press Releases April 30, 2026 05:35 AM

WeRide to Report First Quarter 2026 Financial Results on Wednesday, May 13, 2026

WeRide Inc. announces Q1 2026 earnings release and conference call details.

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
WRD

WeRide Inc., a leading autonomous driving technology company and publicly traded robotaxi pioneer, will release its unaudited financial results for Q1 2026 on May 13, 2026, before U.S. market open. The company will host a bilingual earnings conference call to discuss the results. WeRide operates in over 40 cities across 12 countries and has autonomous driving permits in eight markets, providing autonomous driving solutions across mobility, logistics, and sanitation sectors.

WeRide to Report First Quarter 2026 Financial Results on Wednesday, May 13, 2026
WRD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • WeRide will report its first quarter 2026 financial results before U.S. markets open on May 13, 2026.
  • The company operates autonomous vehicles in more than 40 cities across 12 countries and holds driving permits in eight markets including the U.S.
  • WeRide provides autonomous driving products and services ranging from L2 to L4, targeting mobility, logistics, and sanitation industries.

NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEX: 0800), a global leader in autonomous driving technology, today announced that it will release its unaudited financial results for the first quarter 2026 on Wednesday, May 13, 2026, before the open of the U.S. markets.

The Company’s management will host an earnings conference call at 8:00 A.M. U.S. Eastern Time on May 13, 2026 or 8:00 P.M. Hong Kong Time on the same day to discuss the results. Details for the conference call are as follows:

Event Title: WeRide Inc. First Quarter 2026 Earnings Call

English Registration Link: https://register-conf.media-server.com/register/BI4f8923e8635f4caebcbd76616557ca14

Chinese Simultaneous Interpretation Registration Link (listen-only mode): https://register-conf.media-server.com/register/BI6622e7a1888d405d82d9f8ee057ac85c

All participants are required to complete the online registration in advance using the links provided above. During the registration, participants may select either the English or Chinese simultaneous interpretation options. Please note that the Chinese simultaneous interpretation line will be available in listen-only mode. Upon successful registration, each participant will receive a confirmation email containing the relevant dial-in details and a unique access PIN, which can be used to join the conference call.

Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at https://ir.weride.ai.

About WeRide

WeRide is a global leader and a first mover in the autonomous driving industry, as well as the first publicly traded robotaxi company. Our autonomous vehicles have been tested or operated in over 40 cities across 12 countries. We are also the first and only technology company whose products have received autonomous driving permits in eight markets: China, the UAE, Singapore, France, Switzerland, Saudi Arabia, Belgium, and the US. Empowered by the smart, versatile, cost-effective, and highly adaptable WeRide One platform, WeRide provides autonomous driving products and services from L2 to L4, addressing transportation needs in the mobility, logistics, and sanitation industries. WeRide was named to Fortune’s 2025 Change the World and 2025 Future 50 lists.

Contacts

Investor inquiries: ir@weride.ai
Press inquiries: pr@weride.ai

Piacente Financial Communications
E-mail: weride@thepiacentegroup.com


Risks

  • The financial results are currently unaudited and subject to revision, which may introduce uncertainty.
  • Global regulatory environments for autonomous driving vary and could impact operations or growth in different markets.
  • Market adoption rates for autonomous vehicle technologies remain uncertain and could affect future revenues.

More from Press Releases

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026 Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026